In December 2022, just a month before her second birthday, India’s parents received
the devastating news of their daughter being diagnosed with stage 4 high-risk
neuroblastoma, an uncommon and challenging form of cancer. Despite the numerous
challenges she faced, India demonstrated immense courage and resilience in enduring
intensive and life-saving treatments, defying all odds. Her bravery has opened up an
opportunity for her to participate in a groundbreaking clinical trial at the renowned
Sloan Kettering Cancer Center in New York. However, this journey comes with
significant costs and challenges.
India’s battle with neuroblastoma has been an arduous one so far. She has gone
through multiple rounds of chemotherapy, a complex surgery, stem cell transplant,
radiotherapy, and most recently, immunotherapy. Throughout this grueling journey,
she faced setbacks and spent countless days in the intensive care unit. However, her
unwavering determination and spirit have provided hope, even during the darkest
times.
In recent weeks, India has reached a milestone in her treatment as she has successfully
completed her intensive therapies. Slowly returning to a semblance of normality in her
young life, she has bid farewell to her feeding tube and joyfully resumed activities like
attending Montessori and even participating in a ballet recital. These moments of
happiness have brought immense joy to India, her family, and all those who have been
following her courageous fight.
Yet, the harsh reality of neuroblastoma remains—the constant lurking threat of
relapse. To ensure India’s chances of survival, we urgently seek your assistance in
enabling her access to a groundbreaking clinical trial at the world-renowned Memorial
Sloan Kettering Cancer Center in New York. Participation in this trial offers the highest
potential to prevent the cancer from recurring, increasing India’s long-term survival
chances.
By supporting India’s journey, you are not only changing her life but also
revolutionizing the treatment for numerous children who may face the devastating
diagnosis of neuroblastoma in the future. Your contribution goes beyond helping one
individual; it fosters hope for all those affected by this challenging disease.
However, embarking on this monumental endeavor comes at a considerable cost. The
clinical trial requires extensive ongoing medical fees and multiple trips to New York
over a three-year period. While India’s family is determined to bear as much of the
financial burden as possible, they now appeal to your generosity and compassion to
help achieve their goal of accompanying their beloved little girl to New York and
ensuring she receives the best possible care.
Let us join forces to support India and stand by her family as they navigate this
demanding journey. Your support and contributions will not only provide India with a
lifeline but also bring rays of hope to countless families confronting the challenges of
neuroblastoma. Together, we can make a profound and lasting difference in the fight
against this merciless disease.
India’s loving family has taken the initiative to create a GoFundMe campaign, setting a
towering target of €500K. The aim is to gather the necessary funds to support India’s
participation in the clinical trial and alleviate the financial burden associated with this
transformative process. To donate and stay updated on India’s journey, please follow
this link:
Associazione Annachiara 